Symbol="STOK"
AssetType="Common Stock"
Name="Stoke Therapeutics Inc"
Description="Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops new antisense oligonucleotide (ASO) drugs to treat the underlying causes of serious genetic diseases in the United States. The company is headquartered in Bedford, Massachusetts."
CIK="1623526"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3 PRESTON COURT, BEDFORD, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="245688000"
EBITDA="-110072000"
PERatio="None"
PEGRatio="None"
BookValue="4.303"
DividendPerShare="0"
DividendYield="0"
EPS="-1.33"
RevenuePerShareTTM="0.214"
ProfitMargin="0"
OperatingMarginTTM="-12.7"
ReturnOnAssetsTTM="-0.251"
ReturnOnEquityTTM="-0.506"
RevenueTTM="8844000"
GrossProfitTTM="12405000"
DilutedEPSTTM="-1.33"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.717"
AnalystTargetPrice="21"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="35.82"
PriceToBookRatio="1.619"
EVToRevenue="8.87"
EVToEBITDA="-0.807"
Beta="0.313"
num_52WeekHigh="18.33"
num_52WeekLow="5.22"
num_50DayMovingAverage="9.38"
num_200DayMovingAverage="9.35"
SharesOutstanding="44188500"
DividendDate="None"
ExDividendDate="None"
symbol="STOK"
open="5.48"
high="5.72"
low="5.44"
price="5.48"
volume="310391.00"
latest_trading_day="2023-08-18"
previous_close="5.56"
change="-0.08"
change_percent="-1.4388%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="42"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="58"
Volume_recent_avg="355696"
Change_recent_avg="0.01"
Delta_recent_avg="0.65"
Variance_recent_avg="0.33"
Change_ratio_recent_avg="-0.08"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="58"
Aroon_momentum_negative="42"
image_negative_thumbnail_id_1="496"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0109.jpeg"
image_negative_thumbnail_id_2="1158"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0192.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="582"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_positive_thumbnail_id_1="691"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_positive_thumbnail_id_2="1011"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0173.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
